DENI saw its Momentum Indicator move above the 0 level on December 16, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator turned positive. In of the 43 cases, the stock moved higher in the following days. The odds of a move higher are at .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DENI's RSI Indicator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 45 cases where DENI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for DENI just turned positive on December 12, 2024. Looking at past instances where DENI's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 216 cases where DENI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: DENI's P/B Ratio (0.000) is slightly lower than the industry average of (1.030). P/E Ratio (0.000) is within average values for comparable stocks, (18.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.366). Dividend Yield (0.054) settles around the average of (0.058) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (2.921).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DENI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Industry RegionalBanks
A.I.dvisor tells us that DENI and CBWA have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DENI and CBWA's prices will move in lockstep.
Ticker / NAME | Correlation To DENI | 1D Price Change % | ||
---|---|---|---|---|
DENI | 100% | N/A | ||
CBWA - DENI | 24% Poorly correlated | N/A | ||
USMT - DENI | 23% Poorly correlated | N/A | ||
BCAL - DENI | 22% Poorly correlated | -4.81% | ||
NIDB - DENI | 21% Poorly correlated | -1.52% | ||
EBSH - DENI | 9% Poorly correlated | N/A | ||
More |